Tracked deals
3
3 tracked deals across 2021-2026.
Public Company
Healthcare
Eurofins Scientific
Luxembourg, Luxembourg, Luxembourg
Global scientific testing and laboratory services network performing large volumes of analytical testing across food, environmental, pharmaceutical/biopharma and clinical diagnostics, offering a broad portfolio of analytical methods and lab services to support safety, identity, composition and authenticity testing.
- Focus Areas
- Bioanalytical testing, Clinical diagnostic testing, Drug discovery services
- Website
- eurofins.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 divestiture
Eurofins Scientific Acquisition Volume by Year
Last 3 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
- Buyer
- Eurofins Scientific
- Target
- Element Materials Technology's North American Life Sciences Testing Services business
- Seller
- Element Materials Technology
- Industry
- Healthcare Services
- Type
- Divestiture
Eurofins Scientific agreed to acquire Element Materials Technology's North American Life Sciences Testing Services business for an enterprise value of $400 million. The business operates 27 laboratories and facilities in the United States and Canada and employs approximately 750 people; Eurofins completed the acquisition on October 1, 2026.
-
July 29, 2022
- Buyer
- Eurofins Scientific
- Target
- WESSLING Hungary
- Industry
- Environmental Services
- Location
- Budapest, Hungary
- Type
- Buyout
Eurofins Scientific has completed the acquisition of WESSLING Hungary, a Budapest-based environmental, food and BioPharma product testing laboratory. The deal expands Eurofins’ laboratory footprint and capabilities in Hungary and Central and Eastern Europe, adding ~€15m in revenue and over 300 employees.
-
February 18, 2021
- Buyer
- Eurofins Scientific
- Target
- Beacon Discovery
- Industry
- Biotechnology
- Location
- California, United States
- Type
- Buyout
Eurofins Scientific has agreed to acquire Beacon Discovery, a San Diego–based drug discovery CRO specializing in GPCR research and compound libraries. The acquisition expands Eurofins Discovery’s integrated drug discovery capabilities, adding GPCR expertise and proprietary compound resources to support pharmaceutical and biotech clients. The transaction is expected to close in the coming weeks subject to customary conditions.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
1 tracked deal by Eurofins Scientific.
Environmental Services Buyers & Acquisitions
1 tracked deal by Eurofins Scientific.
Healthcare Services Buyers & Acquisitions
1 tracked deal by Eurofins Scientific.
Acquisitions in California
1 tracked deal by Eurofins Scientific.
Selling a company? Get in front of buyers like Eurofins Scientific
Turn tracked acquisition activity into an outreach-ready buyer list.